A cluster of nontuberculous mycobacterial endophthalmitis (NTME) cases after cataract surgery: clinical features and treatment outcomes

Eye
Cherng-Ru HsuYun-Hsiang Chang

Abstract

To report the clinical features and treatment outcomes in a cluster of patients with endophthalmitis after cataract surgery caused by nontuberculous mycobacterium. Retrospective chart review and noncomparative, consecutive case series. Nine consecutive cases of endophthalmitis, after cataract surgery in a local clinic, were referred to our hospital. The treatment outcomes and analysis of risk factors for infection are reported. The major symptoms at presentation were pain, redness, and decreased vision. Best-corrected visual acuity at presentation ranged from hand motion in two cases (22%), counting fingers at 30 cm in three cases (33%), 20/100 in two cases (20%), 20/63 in one case (11%), to 20/50 in one (11%) case. The mean duration between cataract surgery to presentation at our hospital was 16.7 days. Prompt intravitreal injections (IVI) of amikacin (0.4 mg/0.1 mL) and vancomycin (1 mg/0.1 mL), with topical moxifloxacin were administered initially. Pars plana vitrectomy with amikacin (10 mg/L) and vancomycin (20 mg/L) intravitreal irrigation, and intraocular lens removal were performed for all patients. Systemic antibiotics including amikacin and tigecycline were prescribed for 10 days, and clarithromycin was prescribed for ...Continue Reading

References

Apr 15, 1989·American Journal of Ophthalmology·T J RousselJ P Whitcher
Sep 15, 1989·American Journal of Ophthalmology·J S AmblerT J Spech
Mar 1, 1994·The British Journal of Ophthalmology·D S Hughes, R J Hill
Jan 1, 1996·Retina·S MutyalaC J Papasian
Apr 16, 2003·Archives of Ophthalmology·Ingrid U ScottDarlene Miller
Jan 1, 1959·The Medical Clinics of North America·E H RUNYON
Jan 1, 2004·European Journal of Ophthalmology·P Marín-CasanovaA García-Tapia
Sep 12, 2006·Retina·Licia C V MatieliAna Luisa Hofling-Lima
Sep 10, 2011·Clinical & Experimental Ophthalmology·Dalia O GirgisDarlene Miller
Apr 21, 2012·Survey of Ophthalmology·Ramana S MoorthyNarsing A Rao
Mar 25, 2014·Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi·Jia-Horung HungFu-Chin Huang
Jun 25, 2015·BioMed Research International·Wajiha J KheirRola N Hamam
Jul 22, 2016·Journal of Ophthalmic Inflammation and Infection·Remya Mareen PauloseSavitri Sharma

❮ Previous
Next ❯

Citations

Nov 25, 2020·BMC Infectious Diseases·Warinyupa PinitpuwadolPitipol Choopong
Nov 7, 2020·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Tapan P PatelVaidehi S Dedania

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.